Navigation Links
Future Role of Market Research Made Clear in New Report from Best Practices, LLC
Date:5/12/2010

is report are:

  • Market Research Roles & Responsibilities
  • Use of Outside Resources
  • Market Research Talent Selection & Development
  • Metrics & Performance

Data for this study were collected utilizing primary research via an online survey that drew 42 representatives from 35 companies in the pharmaceutical, biotechnology and medical device sectors. In addition, six interviews were conducted with selected participants. Study participants included Abbott, Bayer, Boehringer Ingelheim, Alcon, EMD Serono, GlaxoSmithKline, Merck, Johnson & Johnson, Novo Nordisk, Pfizer, Vertex, Ortho-McNeil and Wyeth.

Among the key findings in this report are:

  • Currently, New Product Development and Strategic Planning responsibilities are split between Market Research and other organizations. A strong refocusing on development and planning suggests Market Research's vital role in strategic decision support. 

  • More than two-thirds of respondents believe Market Research will balance strategic and tactical work in three to five years. Few believe tactical market research will be the main focus of the function in three to five years.

To learn more about this report, download a complimentary excerpt at http://www3.best-in-class.com/rr998.htm. For related research, visit our Best Practices, LLC Web site at

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Is there a micro-supercapacitor in your future?
2. Reportlinker Adds Future of Red Biotechnology in China
3. Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders
4. Gloabl Harvest Initiative: Taking Down Fences To Meet Future Needs
5. New graphene nanomesh could change the future of electronics
6. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
7. Single-step technique produces both p-type and n-type doping for future graphene devices
8. What's Next for Stevia? Experts from GLG Life Tech Corp Share Views on Stevia's Future at Complimentary Webinar on 17 Feb.
9. InfoSpi Shall Benefit From Contract for Future Use of IBS Technology
10. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
11. Nanowires key to future transistors, electronics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a commercial focus on China , ... (CFDA) has approved the Company,s application to conduct a ... carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an ... and monetization of intellectual property, today provided an ... and  Spherix v. Uniden , Case No. 3:13-cv-03496-M, ... the Northern District of Texas ... Verizon, Case No. 1:14-cv-00721-GBL-TCB, in the United ...
(Date:3/30/2015)... March 30, 2015  Naldemedine, an investigational peripherally ... Shionogi & Co., Ltd., met its primary and ... I) for the treatment of opioid-induced constipation (OIC) ... opioid therapy. Study results showed that naldemedine (0.2 ... the frequency of spontaneous bowel movement (SBM) compared ...
(Date:3/29/2015)... 2015  Caris Life Sciences® today announced the ... Intelligence®, the company,s panomic, comprehensive tumor profiling service, ... rare and difficult to treat gynecological cancers may ... to improve patient outcomes. These studies were presented ... of Gynecologic Oncology (SGO) 2015 Annual Meeting on ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4
... Criteria Included a Focus on Research and Respect for ... ... Lilly and Company,(NYSE: LLY ) announced today that it has made ... Science,s 2008 survey polled nearly 4,000 employees from,500 employers in the biotechnology, ...
... Inc.,(Nasdaq: ENMD ) a clinical-stage pharmaceutical company ... diseases,announced today that Thomas H. Bliss, Jr., EntreMed,s ... a Company,overview at the 16th Annual BioPartnering Europe ... London, United Kingdom. Mr. Bliss, presentation,is scheduled for ...
... got a new competitor this week with a stronger and ... team of researchers from four U.S. institutions. , Scientists have ... scurry up walls and cling to ceilings by their toes. ... elastic hairs in their toes that take advantage of atomic-scale ...
Cached Biology Technology:Lilly Recognized as One of the World's Top Biopharmaceutical Employers 2EntreMed to Present at BioPartnering Europe Conference 2EntreMed to Present at BioPartnering Europe Conference 3Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 2Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 3Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 4
(Date:3/11/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) ... Market by Product, Application & By Geography - Global ... offering. , This report predicts that the ... by 2020, with an estimated CAGR of 10.6%. ... types such as contact cards & readers, contactless cards ...
(Date:3/10/2015)... Utah , March 10, 2015   Tute ... interpretation, has been selected by next-generation sequencing company ... of whole exome and targeted gene panel interpretation. ... provider, has adopted the most current technologies to support ... genetic research. The company offers two types of exome ...
(Date:3/3/2015)... Calif. , March 3, 2015 /PRNewswire/ ... leading provider of advanced cryogenic logistics solutions ... including immunotherapies, stem cells, cell lines, clinical ... reproductive medicine, today announced the expansion of ... Research Centers, ("Fred Hutch") Clinical Research ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... Many plants can pollinate themselves and reproduce without the aid ... parts. But the short-term perks of being able to go ... in the journal Science . The reason is because ... scientists say. Flowering plants are incredibly creative when it ...
... this study show that fearless behavior in children can ... predisposition. This type of behavior has less correlation ... processes or parenting practice," says Dr. Inbal Kivenson-Baron, who ... fearless behavior also reveal less empathy and more aggression ...
... , Learning a hobby or other complex task in childhood ... the emergence of a personality disorder (PD) later on in ... journal, Development and Psychopathology . Spending time ... or teaching them organizational skills helps to foster better psychological ...
Cached Biology News:Single parenthood doesn't pay off for plants 2Fearless children show less empathy, more aggression 2Play with your kid, for their mental health's sake 2Play with your kid, for their mental health's sake 3
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
WTAP Antibody...
Biology Products: